Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-10
DOI
10.1038/s41598-020-63240-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016
- (2019) Michael A Pfaller et al. Open Forum Infectious Diseases
- Changing trends in epidemiology and antifungal susceptibility patterns of six bloodstream Candida species isolates over a 12-year period in Kuwait
- (2019) Ziauddin Khan et al. PLoS One
- Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs
- (2019) Suhail Ahmad et al. MYCOSES
- Lack of detection of Candida nivariensis and Candida bracarensis among 440 clinical Candida glabrata sensu lato isolates in Kuwait
- (2019) Mohammad Asadzadeh et al. PLoS One
- Invasive Candida auris infections in Kuwait hospitals: epidemiology, antifungal treatment and outcome
- (2018) Ziauddin Khan et al. INFECTION
- Molecular Epidemiology and Antifungal Susceptibility of Candida glabrata in China (August 2009 to July 2014): A Multi-Center Study
- (2017) Xin Hou et al. Frontiers in Microbiology
- Multicenter Comparison of the Etest and EUCAST Methods for Antifungal Susceptibility Testing of Candida Isolates to Micafungin
- (2016) M.-E. Bougnoux et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid Detection ofFKS-Associated Echinocandin Resistance in Candida glabrata
- (2016) Yanan Zhao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
- (2016) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- Drug resistance mechanisms and their regulation in non-albicans Candidaspecies
- (2016) Anna Kołaczkowska et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evaluation of Polymorphic Locus Sequence Typing for Candida glabrata Epidemiology
- (2016) Santosh Katiyar et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The epidemiology and outcomes of invasiveCandidainfections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)
- (2016) David R. Andes et al. Transplant Infectious Disease
- Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance
- (2016) Kelley R. Healey et al. Nature Communications
- Echinocandin Resistance in Candida Species: a Review of Recent Developments
- (2016) Nathan P. Wiederhold Current Infectious Disease Reports
- MALDI-TOF typing highlights geographical and fluconazole resistance clusters in Candida glabrata
- (2015) C. Dhieb et al. MEDICAL MYCOLOGY
- Antifungal drug resistance amongCandidaspecies: mechanisms and clinical impact
- (2015) Maurizio Sanguinetti et al. MYCOSES
- Simple, Low-Cost Detection of Candida parapsilosis Complex Isolates and Molecular Fingerprinting of Candida orthopsilosis Strains in Kuwait by ITS Region Sequencing and Amplified Fragment Length Polymorphism Analysis
- (2015) Mohammad Asadzadeh et al. PLoS One
- Role of FKS Mutations in Candida glabrata: MIC Values, Echinocandin Resistance, and Multidrug Resistance
- (2014) Cau D. Pham et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isolation of cholesterol-dependent, multidrug-resistant Candida glabratastrains from blood cultures of a candidemia patient in Kuwait
- (2014) Ziauddin Khan et al. BMC INFECTIOUS DISEASES
- Global trends in the distribution of Candida species causing candidemia
- (2014) J. Guinea CLINICAL MICROBIOLOGY AND INFECTION
- Assessment of caspofungin susceptibility of Candida glabrata by the Etest®, CLSI, and EUCAST methods, and detection of FKS1 and FKS2 mutations
- (2014) N. Bourgeois et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period
- (2014) Arnaldo L. Colombo et al. INTENSIVE CARE MEDICINE
- Emergence of Resistance to Amphotericin B and Triazoles inCandida glabrataVaginal Isolates in a Case of Recurrent Vaginitis
- (2014) Z.U. Khan et al. JOURNAL OF CHEMOTHERAPY
- Breakthrough Invasive Candida glabrata in Patients on Micafungin: a Novel FKS Gene Conversion Correlated with Sequential Elevation of MIC
- (2014) T. Saraya et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Set of Classical PCRs for Detection of Mutations in Candida glabrata FKS Genes Linked with Echinocandin Resistance
- (2014) C. Dudiuk et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008
- (2014) Michael A. Pfaller et al. PLoS One
- Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?
- (2013) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic Failure
- (2013) James S. Lewis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison between the EUCAST Procedure and the Etest for Determination of the Susceptibility of Candida Species Isolates to Micafungin
- (2013) Laura Judith Marcos-Zambrano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Editorial Commentary: Candida glabrata and FKS Mutations: Witnessing the Emergence of the True Multidrug-Resistant Candida
- (2013) L. Ostrosky-Zeichner CLINICAL INFECTIOUS DISEASES
- Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
- (2013) Barbara D. Alexander et al. CLINICAL INFECTIOUS DISEASES
- ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of rare invasive yeast infections
- (2013) M.C. Arendrup et al. CLINICAL MICROBIOLOGY AND INFECTION
- Use of Micafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 3,764 Clinical Isolates of Candida by Use of CLSI Methods and Interpretive Criteria
- (2013) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance
- (2013) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Facultative Sterol Uptake in an Ergosterol-Deficient Clinical Isolate of Candida glabrata Harboring a Missense Mutation inERG11and Exhibiting Cross-Resistance to Azoles and Amphotericin B
- (2012) Claire M. Hull et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Caspofungin Etest Susceptibility Testing of Candida Species: Risk of Misclassification of Susceptible Isolates of C. glabrata and C. krusei when Adopting the Revised CLSI Caspofungin Breakpoints
- (2012) Maiken Cavling Arendrup et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Two Clinical Isolates of Candida glabrata Exhibiting Reduced Sensitivity to Amphotericin B Both Harbor Mutations inERG2
- (2012) Claire M. Hull et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Presence of anFKSMutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata
- (2012) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Changes in Incidence and Antifungal Drug Resistance in Candidemia: Results From Population-Based Laboratory Surveillance in Atlanta and Baltimore, 2008-2011
- (2012) A. A. Cleveland et al. CLINICAL INFECTIOUS DISEASES
- The changing epidemiology of healthcare-associated candidemia over three decades
- (2012) Daniel Diekema et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Species Identification and Antifungal Susceptibility Testing of Candida Bloodstream Isolates from Population-Based Surveillance Studies in Two U.S. Cities from 2008 to 2011
- (2012) S. R. Lockhart et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Candida dubliniensis: An Appraisal of Its Clinical Significance as a Bloodstream Pathogen
- (2012) Ziauddin Khan et al. PLoS One
- Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi
- (2012) C. L. Schoch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment
- (2011) Michael A. Pfaller AMERICAN JOURNAL OF MEDICINE
- Comparison of micafungin MICs as determined by the Clinical and Laboratory Standards Institute broth microdilution method (M27-A3 document) and Etest for Candida spp. isolates
- (2011) Ana Espinel-Ingroff et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- FKS Mutations and Elevated Echinocandin MIC Values among Candida glabrata Isolates from U.S. Population-Based Surveillance
- (2010) A. J. Zimbeck et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- CandidaBloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009
- (2010) Michael A. Pfaller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: Time for harmonization of CLSI and EUCAST broth microdilution methods
- (2010) M.A. Pfaller et al. DRUG RESISTANCE UPDATES
- Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3- -D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint
- (2009) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cryptococcus randhawai sp. nov., a novel anamorphic basidiomycetous yeast isolated from tree trunk hollow of Ficus religiosa (peepal tree) from New Delhi, India
- (2009) Zia U. Khan et al. ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY
- Identification of Candida nivariensis and Candida bracarensis in a Large Global Collection of Candida glabrata Isolates: Comparison to the Literature
- (2009) S. R. Lockhart et al. JOURNAL OF CLINICAL MICROBIOLOGY
- A Nonsense Mutation in the ERG6 Gene Leads to Reduced Susceptibility to Polyenes in a Clinical Isolate of Candida glabrata
- (2008) P. Vandeputte et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal susceptibility of clinical Candida parapsilosis isolates in Kuwait
- (2008) Mohammad Asadzadeh et al. MYCOSES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now